Notify me when BRISTOL MYERS SQUIBB CO files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CGEN | COMPUGEN LTD | Ordinary Shares, par value NIS 0.01 | 2.1% | $2,318,571 | 1,840,136 | BRISTOL MYERS SQUIBB CO | 31 Dec 2024 | ||
| CELU | Celularity Inc | Class A Common stock, par value $0.0001 per share | 1.9% | $174,813 | 426,372 | BRISTOL MYERS SQUIBB CO | 31 Dec 2024 | ||
| QTTB | Q32 Bio Inc. | Common stock, par value $0.0001 per share | 1.6% | $416,508 | 200,244 | BRISTOL MYERS SQUIBB CO | 31 Dec 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|